Editorial desk
Corrections make the map better
Notes on citations, superseded findings and misattributed studies are the most useful correspondence this desk receives.
Editorial correspondence
The most valuable message this desk gets is a correction to the record: a figure quoted loosely, a study attributed to the wrong molecule, a regulatory status that has moved, or a peer-reviewed paper on CJC-1295, ipamorelin, sermorelin or MOTS-c that belongs on the references page. Pharmacokinetic corrections are especially welcome, since the DAC and no-DAC forms of CJC-1295 are the single easiest place on this map for a number to end up beside the wrong compound.
A note is easiest to act on when it names three things: the page, the exact passage, and the supporting source. In that shape a proposed change can be checked against its origin before the map is redrawn, which is the only revision process this site runs.
Editorial mailbox: editors@precisionpeptideplanner.com
Past the edge of this map
So that no message goes unanswered for the wrong reason, several kinds of request sit outside what an editorial desk can do. This site reads and charts the literature; it does not practise medicine, dispense anything, or hold a view about any individual's situation. It therefore cannot advise on or endorse human use of any compound described here, name a dose, schedule, route or interval for anyone, judge whether a cited finding applies to a particular person, or help locate, price or source material from any supplier.
It also cannot advise athletes subject to testing beyond one flat fact already on every page: all four compounds are prohibited in sport, and validated detection methods exist for the class. Medical questions belong with a licensed clinician in the correspondent's own jurisdiction.
Replies are read but not guaranteed, and the mailbox is checked on an editorial rather than a commercial cadence.